Suchergebnisse - "Biard, Lucie"

PubPharm (5)

1

Surv-CRM-12 : A Bayesian phase I/II survival CRM for right-censored toxicity endpoints with competing disease progression

enthalten in: Statistics in medicine | 2022

von Andrillon, A. | Chevret, S. | Lee, S. | +1

2

DICE : A Bayesian model for early dose finding in phase I trials with multiple treatment courses

enthalten in: Biometrical journal. Biometrische Zeitschrift | 2022

von Ursino, M. | Biard, L. | Chevret, S.

3

Seamless phase I/II design for novel anticancer agents with competing disease progression

enthalten in: Statistics in medicine | 2021

von Biard, L. | Lee, S. | Cheng, B.

4

Dose-finding design and benchmark for a right censored endpoint

enthalten in: Journal of biopharmaceutical statistics | 2020

von Andrillon, A. | Chevret, S. | Lee, S. | +1

5

¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer : Influence of the Chemotherapy Regimen

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2016

von Groheux, D. | Biard, L. | Giacchetti, S. | +9

1
[1]